» Articles » PMID: 16533808

A C-terminal Lysine That Controls Human P2X4 Receptor Desensitization

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Mar 15
PMID 16533808
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor desensitization can determine the time course of transmitter action and profoundly alter sensitivity to drugs. Among P2X receptors, ion currents through homomeric P2X4 receptors exhibit intermediate desensitization when compared with P2X1 and P2X3 (much faster) and P2X2 and P2X7 (slower). We recorded membrane currents in HEK293 cells transfected to express the human P2X4 receptor. The decline in current during a 4-s application of ATP (100 microm) was about 30%; this was not different during whole-cell or perforated patch recording. Alanine-scanning mutagenesis of the intracellular C terminus identified two positions with much accelerated desensitization kinetics (Lys373: 92% and Tyr374: 74%). At position 373, substitution of Arg or Cys also strongly accelerated desensitization: however, in the case of K373C the wild-type phenotype was fully restored by adding ethylammonium methanethiosulfonate. At position 374, phenylalanine could replace tyrosine. These results indicate that wild-type desensitization properties requires an aromatic moiety at position 374 and an amino rather than a guanidino group at position 373. These residues lie between previously identified motifs involved in membrane trafficking (YXXXK and YXXGL) and implicates the C-terminal also in rearrangements leading to channel closing during the presence of agonist.

Citing Articles

Human P2X4 receptor gating is modulated by a stable cytoplasmic cap and a unique allosteric pocket.

Shi H, Ditter I, Oken A, Mansoor S Sci Adv. 2025; 11(3):eadr3315.

PMID: 39823330 PMC: 11740937. DOI: 10.1126/sciadv.adr3315.


Finely ordered intracellular domain harbors an allosteric site to modulate physiopathological function of P2X3 receptors.

Lin Y, Lu Y, Li C, Ma X, Shao M, Gao Y Nat Commun. 2024; 15(1):7652.

PMID: 39227563 PMC: 11372093. DOI: 10.1038/s41467-024-51815-7.


Genetically-encoded BRET probes shed light on ligand bias-induced variable ion selectivity in TRPV1 and P2X5/7.

Chappe Y, Pierredon S, Joushomme A, Molle P, Garenne A, Canovi A Proc Natl Acad Sci U S A. 2022; 119(46):e2205207119.

PMID: 36343259 PMC: 9674215. DOI: 10.1073/pnas.2205207119.


The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.

Sophocleous R, Ooi L, Sluyter R Int J Mol Sci. 2022; 23(10).

PMID: 35628550 PMC: 9147237. DOI: 10.3390/ijms23105739.


Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases.

Braganca B, Correia-de-Sa P Int J Mol Sci. 2020; 21(14).

PMID: 32679900 PMC: 7404342. DOI: 10.3390/ijms21145005.